Literature DB >> 25254927

Predicting the structures of complexes between phosphoinositide 3-kinase (PI3K) and romidepsin-related compounds for the drug design of PI3K/histone deacetylase dual inhibitors using computational docking and the ligand-based drug design approach.

Akifumi Oda1, Ken Saijo2, Chikashi Ishioka2, Koichi Narita3, Tadashi Katoh3, Yurie Watanabe4, Shuichi Fukuyoshi4, Ohgi Takahashi3.   

Abstract

Predictions of the three-dimensional (3D) structures of the complexes between phosphoinositide 3-kinase (PI3K) and two inhibitors were conducted using computational docking and the ligand-based drug design approach. The obtained structures were refined by structural optimizations and molecular dynamics (MD) simulations. The ligands were located deep inside the ligand binding pocket of the p110α subunit of PI3K, and the hydrogen bond formations and hydrophobic effects of the surrounding amino acids were predicted. Although rough structures were obtained for the PI3K-inhibitor complexes before the MD simulations, the refinement of the structures by these simulations clarified the hydrogen bonding patterns of the complexes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computational docking; Dual inhibitor; Molecular dynamics simulation; Molecular superposition; Phosphoinositide 3-kinase; Romidepsin

Mesh:

Substances:

Year:  2014        PMID: 25254927     DOI: 10.1016/j.jmgm.2014.08.007

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  2 in total

1.  Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.

Authors:  Ken Saijo; Hiroo Imai; Sonoko Chikamatsu; Koichi Narita; Tadashi Katoh; Chikashi Ishioka
Journal:  Cancer Sci       Date:  2017-05-19       Impact factor: 6.716

2.  Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.

Authors:  Ken Saijo; Jin Imamura; Koichi Narita; Akifumi Oda; Hideki Shimodaira; Tadashi Katoh; Chikashi Ishioka
Journal:  Cancer Sci       Date:  2015-01-28       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.